The revenue zoomed 21.61% to Rs. 5825.01 millions for the quarter ended March 2026 as compared to Rs. 4789.84 millions during the corresponding quarter last year.Handsome Net Profit growth of 72.70% reported above the corresponding previous quarter figure of Rs. 2116.64 millions to Rs. 1225.62 millions.The company reported a good operating profit of 3276.16 millions compared to 2359.30 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202603	202503	% Var	202603	202503	% Var	202603	202503	% Var
Sales	5825.01	4789.84	21.61	20893.12	18406.49	13.51	20893.12	18406.49	13.51
Other Income	606.25	378.19	60.30	1820.75	1094.40	66.37	1820.75	1094.40	66.37
PBIDT	3276.16	2359.30	38.86	10331.96	7984.49	29.40	10331.96	7984.49	29.40
Interest	15.83	21.03	-24.73	65.47	90.89	-27.97	65.47	90.89	-27.97
PBDT	3270.04	2338.27	39.85	10026.36	7893.60	27.02	10026.36	7893.60	27.02
Depreciation	262.84	209.89	25.23	995.65	779.37	27.75	995.65	779.37	27.75
PBT	3007.20	2128.38	41.29	9030.71	7114.23	26.94	9030.71	7114.23	26.94
TAX	890.56	902.76	-1.35	2325.06	2052.36	13.29	2325.06	2052.36	13.29
Deferred Tax	-6.50	337.32	-101.93	-87.99	232.08	-137.91	-87.99	232.08	-137.91
PAT	2116.64	1225.62	72.70	6705.65	5061.87	32.47	6705.65	5061.87	32.47
Equity	1123.43	1118.15	0.47	1123.43	1118.15	0.47	1123.43	1118.15	0.47
PBIDTM(%)	56.24	49.26	14.18	49.45	43.38	14.00	49.45	43.38	14.00

Anthem Biosciences Ltd.